SARS-CoV-2 N Protein Triggers Acute Lung Injury via Modulating Macrophage Activation and Infiltration in in vitro and in vivo

References

• Osuchowski MF, Winkler MS, Skirecki T, et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med. 2021;9:622–642. doi:10.1016/S2213-2600(21)00218-6
   PubMed Web of Science ®Google Scholar
• Wendisch D, Dietrich O, Mari T, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243–61 e27. doi:10.1016/j.cell.2021.11.033
   PubMed Web of Science ®Google Scholar
• Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036–45 e9. doi:10.1016/j.cell.2020.04.026
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Papanikolaou V, Chrysovergis A, Ragos V, et al. From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants. Gene. 2022;814:146134. doi:10.1016/j.gene.2021.146134
   PubMed Web of Science ®Google Scholar
• Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281–92 e6. doi:10.1016/j.cell.2020.02.058
   PubMed Web of Science ®Google Scholar
• Wang W, Chen J, Hu D, et al. SARS-CoV-2 N protein induces acute kidney injury via Smad3-dependent G1 cell cycle arrest mechanism. Adv Sci. 2022;9:e2103248. doi:10.1002/advs.202103248
   Web of Science ®Google Scholar
• Webb BJ, Peltan ID, Jensen P, et al. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol. 2020;2:e754–e63. doi:10.1016/S2665-9913(20)30343-X
   PubMedGoogle Scholar
• Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636–1643. doi:10.1038/s41591-020-1051-9
   PubMed Web of Science ®Google Scholar
• Wang C, Xie J, Zhao L, et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine. 2020;57:102833. doi:10.1016/j.ebiom.2020.102833
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications. Inflammation. 2021;44:13–34. doi:10.1007/s10753-020-01337-3
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80 e8. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Junqueira C, Crespo A, Ranjbar S, et al. FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022;606:576–584. doi:10.1038/s41586-022-04702-4
   PubMed Web of Science ®Google Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355–362. doi:10.1038/s41577-020-0331-4
   PubMed Web of Science ®Google Scholar
• Sharma SB, Melvin WJ, Audu CO, et al. The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation. Blood. 2022;2022:245.
   Google Scholar
• Matute-Bello G, Downey G, Moore BB, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44:725–738. doi:10.1165/rcmb.2009-0210ST
   PubMed Web of Science ®Google Scholar
• Lai DM, Tang J, Chen LS, et al. Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis. Cell Death Dis. 2018;9. doi:10.1038/s41419-018-0412-5
   Web of Science ®Google Scholar
• Ramasamy S, Subbian S. Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clin Microbiol Rev. 2021;34:154.
   Web of Science ®Google Scholar
• Khan S, Shafiei MS, Longoria C, Schoggins JW, Savani RC, Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kappaB pathway. Elife. 2021;10. doi:10.7554/eLife.68563
   Web of Science ®Google Scholar
• Zheng M, Karki R, Williams EP, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22:829–838. doi:10.1038/s41590-021-00937-x
   PubMed Web of Science ®Google Scholar
• Abid S, Marcos E, Parpaleix A, et al. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension. Eur Respir J. 2019;54:e15.
   Web of Science ®Google Scholar
• Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23:3–20. doi:10.1038/s41580-021-00418-x
   PubMed Web of Science ®Google Scholar
• Levy M, Recher M, Hubert H, et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA. 2022;327:281–283. doi:10.1001/jama.2021.23262
   PubMed Web of Science ®Google Scholar
• Pan P, Shen M, Yu Z, et al. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat Commun. 2021;12:4664. doi:10.1038/s41467-021-25015-6
   PubMed Web of Science ®Google Scholar
• Colunga Biancatelli RML, Solopov PA, Sharlow ER, Lazo JS, Marik PE, Catravas JD. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Kappa18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2021;321:L477–L84. doi:10.1152/ajplung.00223.2021
   PubMed Web of Science ®Google Scholar
• Ocal S. SARS-CoV-2 and lung injury: dysregulation of immune response but not hyperimmune response as in “cytokine storm syndrome”. Clin Respir J. 2022;16:13–16. doi:10.1111/crj.13455
   PubMed Web of Science ®Google Scholar
• Xia J, Tang W, Wang J, et al. SARS-CoV-2 N protein induces acute lung injury in mice via NF-kB activation. Front Immunol. 2021;12:791753. doi:10.3389/fimmu.2021.791753
   PubMed Web of Science ®Google Scholar
• Akbarpour M, Lecuona E, Chiu SF, et al. Residual endotoxin induces primary graft dysfunction through ischemia/reperfusion-primed alveolar macrophages. J Clin Invest. 2020;130:4456–4469. doi:10.1172/JCI135838
   PubMed Web of Science ®Google Scholar
• Horng T, Barton GM, Flavell RA, Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 2002;420:329–333. doi:10.1038/nature01180
   PubMed Web of Science ®Google Scholar
• Hsieh WY, Zhou QD, York AG, et al. Toll-like receptors induce signal-specific reprogramming of the macrophage lipidome. Cell Metab. 2020;32:128–43 e5. doi:10.1016/j.cmet.2020.05.003
   PubMed Web of Science ®Google Scholar
• Xu G, Qi F, Li H, et al. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. Cell Discov. 2020;6:73. doi:10.1038/s41421-020-00225-2
   PubMed Web of Science ®Google Scholar